Literature DB >> 7198989

DNA-damage in human cells treated with the closely related alkylating agents peptichemio, m-L-sarcolysin and melphalan.

U Ringborg, B Lambert, R Lewensohn, I Turesson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7198989     DOI： 10.1016/s0277-5379(81)80003-x

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  4 in total

1.  Evidence for increased intracellular transport of m-sarcolysine (alkylating moiety) when combined with two amino acid analogs (PTT-119).

Authors:  F Verlicchi; S Boschi; G Visani; A Guidi; P Tosi; M Cavo; S Tura
Journal:  Blut       Date:  1990-11

2.  Peptichemio induction therapy in myelomatosis.

Authors:  G Merlini; P G Gobbi; A Riccardi; G Riva; C Sardi; S Perugini
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  Persistence of chromosome rearrangements in peripheral lymphocytes from patients treated with melphalan for ovarian carcinoma.

Authors:  B Lambert; K Holmberg; N Einhorn
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

Review 4.  Unequal sister chromatid exchange. A mechanism affecting Ig gene arrangement and expression.

Authors:  S A Tilley; B K Birshtein
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.